Clinical Trials Browser

Interventional × dalotuzumab × Tumor-Agnostic × Clear all

NCT00694356 2018-08-08

Study of Dalotuzumab (MK-0646) in Adults With Solid Tumors (MK-0646-009)

Phase 1 Completed

15 enrolled 13 charts

Neoplasms

NCT00730379 2015-02-10

A Combination Study With Ridaforolimus (MK8669) and Dalotuzumab (MK0646) in Patients With Advanced Cancer (8669-004)

Phase 1 Completed

Neoplasms